Abstract:Objective:To explore the efficacy and influencing factors of radiofrequency ablation (RFA) in the treatment of colorectal cancer liver metastases (CRLM).Methods:The clinical and imaging data of 281 patients (477 intrahepatic metastatic tumors) who received percutaneous RFA treatment in Sir Run Run Shaw Hospital, Zhejiang University School of Medicine from December 2009 to December 2020 were retrospectively analyzed. Factors that may affect the efficacy of RFA were recorded, including carcinoembryonic antigen (CEA), differentiation, extrahepatic metastasis, tumor location and size, complications and other information. Patients were followed up through hospital admissions, telephone, etc. The primary endpoints were overall survival (OS) and local tumor progression-free survival (LTPFS). Univariate and multivariate logistic regression models were used to identify predictors of residual tumor. Univariate and multivariate Cox proportional hazards regression were used to identify the influencing factors of LTPFS and OS. The median LTPFS and OS were estimated by the Kaplan-Meier curve and compared by the log-rank test.Results:After RFA, 68 (14.3%) tumor residues were observed. Multivariate logistic regression showed that the risk factors for residual tumor were size ≥20 mm, high-risk and perivascular location, and minimal ablative margin<5 mm. During the follow-up period, the main complication rate was 4.3% (12/281) and the fatality rate was 31.3% (88/281). At the same time, local tumor progression was found in 167 (35.0%) lesions post-RFA. The median time of LTPFS and OS estimated by the Kaplan Meier method were 35.0 (95%CI 26.53-43.48) and 44.0 (95%CI 29.70-58.30) months, respectively. The cumulative proportion of LTPFS and OS were 37.2% and 40.4% respectively in the 5th year. Multivariate Cox proportional hazard regression showed that CEA≥30 ng/ml, tumor size ≥20 mm, and minimal ablative margin<5 mm were risk factors for LTPFS; extrahepatic metastasis, tumor burden>30 mm, and lesion with minimal ablative margin<5 mm were independent risk factors for OS; re-intervention was an independent protective factor for OS.Conclusions:Adequate ablative margin and less tumor burden were beneficial to local tumor control and long-term survival of patients in the RFA treatment; the existence of extrahepatic metastasis was an important risk factor for OS, and re-interventional therapy was beneficial to extend OS.

Primary Tumour Location is an Important Prognostic Factor in Colorectal Cancer Liver Metastases Following Radiofrequency Ablation

Analysis of therapeutic effect and influencing factors of radiofrequency ablation for colorectal cancer liver metastases

Does Primary Tumor Location Impact the Prognosis of Colorectal Liver Metastases Patients after Microwave Ablation? - Lessons from 10 Years’ Experience

Does the Site of the Primary Affect Outcomes when Ablating Colorectal Liver Metastases with Radiofrequency Ablation?

Comparison of Percutaneous Radiofrequency Ablation for Subcapsular and Non-Subcapsular Colorectal Cancer Liver Metastases

The Association of KRAS Mutation and Primary Tumor Location with Recurrence in Colorectal Liver Metastases Undergoing Radiofrequency Ablation

Significance and prognostic factors in 84 patients with colorectal liver metastases treated with radiofrequency ablation

Periprocedural Risk Factors for Incomplete Radiofrequency Ablation of Liver Metastases from Colorectal Cancer: a Single-Center Retrospective Analysis

The growth pattern of liver metastases on MRI predicts early recurrence in patients with colorectal cancer: a multicenter study

Radiofrequency Ablation Versus Resection for Technically Resectable Colorectal Liver Metastasis: a Propensity Score Analysis

Prognostic impact of primary tumor location in colorectal liver metastases - right-sided colon versus left-sided colon versus rectum: a single-center retrospective study

Different Effects of KRAS Gene on Recurrence for Right- and Left-sided Colorectal Liver Metastases Undergoing Radiofrequency Ablation

Radiofrequency Ablation Vs. Hepatic Resection for Resectable Colorectal Liver Metastases

Elevated Neutrophil to Lymphocyte Ratio Might Predict Poor Prognosis for Colorectal Liver Metastasis after Percutaneous Radiofrequency Ablation

Colorectal liver metastases: a retrospective analysis of 120 patients from a single-institution

The Impact of Primary Tumour Location in Patients Undergoing Hepatic Resection for Colorectal Liver Metastasis.

Survival and Prognostic Factors of Colorectal Liver Metastases after Surgical and Nonsurgical Treatment.

Radiofrequency Ablation Versus Resection For Colorectal Cancer Liver Metastases: A Meta-Analysis

Radiofrequency Ablation versus Liver Resection for Colorectal Cancer Liver Metastasis: An Updated Systematic Review and Meta-analysis

Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation May Be a New Treatment Modality for Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study

Long-Term Outcomes And Prognostic Analysis Of Percutaneous Radiofrequency Ablation In Liver Metastasis From Breast Cancer